InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
67,470.19
(
-0.49%
)
Post# of 252707
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

tony111

Send PM Follow Ignore
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

tony111

Re: DonShimoda post# 87459

Monday, 12/14/2009 4:38:11 PM

Monday, December 14, 2009 4:38:11 PM

Post# of 252707
There are two other rampalogs that are already on the market. From the research that I have done Rida does not have any safety advantage over the other two. Therefore, I am not sure why would someone think Rida is best in class. Also I would think a dual mTORC inhibitor combined with IGF-1R inhibitor would potentially give a better response.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up